ALB and neoplasm: Tissue biodistribution studies of 177Lu-Alb-L2–177Lu-Alb-L6 were performed at 2 h, 24 h, 48 h, and 192 h after injection to evaluate the tumor targeting and clearance of the agents from blood and normal tissues.